The tariff classification of an insulin delivery device from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated June 4, 2025, you requested a tariff classification ruling on behalf of MannKind Corporation (“MannKind”). Additional information was provided via email on June 12, 2025. The V-Go wearable insulin delivery device (all-in-one insulin delivery patch) is a fully mechanical, disposable device designed for diabetic users. It is worn like a patch for 24 hours and provides continuous subcutaneous insulin infusion over 24 hours at a preset basal rate.
The V-Go is designed to mimic the body’s natural steady release of insulin and provides on-demand insulin at mealtimes to address glucose excursions that occur after eating. It replaces both basal and mealtime insulin injections and enables diabetics to receive their required daily insulin without the need for long-acting and mealtime injections.
The device includes a button cover which covers the start button and prevents it from being pushed, an insulin port, a bolus ready button, a viewing window with an indicator to show a view of the insulin reservoir, a bolus delivery button, a needle release button, and an adhesive pad and liner on the bottom of the device. You state that MannKind only markets and sells V-Go to diabetics with a doctor’s prescription. The V-Go is imported without insulin pre-filled.
In your submission you requested consideration of a secondary classification under 9817.00.96, HTSUS, which applies to articles and parts and accessories of articles specifically designed or adapted for the use or benefit of the permanently or chronically physically or mentally handicapped.
Subheading 9817.00.96, HTSUS, covers: “[a]rticles specially designed or adapted for the use or benefit of the blind or other physically or mentally handicapped persons; parts and accessories (except parts and accessories of braces and artificial limb prosthetics) that are specially designed or adapted for use in the foregoing articles: [o]ther.” The term “blind or other physically or mentally handicapped persons” includes “any person suffering from a permanent or chronic physical or mental impairment which substantially limits one or more major life activities, such as caring for one’s self, performing manual tasks, walking, seeing, hearing, speaking, breathing, learning, or working.” U.S. Note 4(a), Subchapter XVII, Chapter 98, HTSUS.
Subheading 9817.00.96, HTSUS, excludes “(i) articles for acute or transient disability; (ii) spectacles, dentures, and cosmetic articles for individuals not substantially disabled; (iii) therapeutic and diagnostic articles; or, (iv) medicine or drugs.” U.S. Note 4(b), Subchapter XVII, Chapter 98, HTSUS. In Sigvaris, Inc. v. United States, 227 F. Supp 3d 1327, 1336 (Ct. Int’l Trade 2017), aff’d, 899 F.3d 1308 (Fed. Cir. 2018), the U.S.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N349799).